Skip to main content
Clinical Trials/NCT03708276
NCT03708276CompletedNot Applicable

Testing a New Multiple Sclerosis Specific Web-based Symptom Self-management Program: My MS Toolkit

University of Michigan1 site in 1 country20 target enrollmentStarted: February 26, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
20
Locations
1
Primary Endpoint
Acceptability of My MS Toolkit

Study Overview

Brief Summary

My MS Toolkit is a web-based symptom self-management program for persons with multiple sclerosis.

This study is evaluating various aspects of My MS Toolkit and how it impacts symptom self-management in multiple sclerosis. The research team believe that the toolkit will be feasible, acceptable, and beneficial to participants.

Detailed Description

Study participants will be asked to use a newly developed web-based symptom self-management program, called the My MS Toolkit, for 12 weeks. Participants will also be asked to complete online surveys throughout the study.

The My MS Toolkit includes 8 modules that describe symptom self-management strategies. Participants will explore the My MS Toolkit on their own, following the prompts and guides built into the program, and are encouraged to practice and apply the skills learned.

The study can be done from participants' homes using a reliable internet-connected device. No travel is required.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Multiple Sclerosis
  • •Have access to a reliable, internet-connected device (e.g. computer, tablet). (Note: this study is conducted electronically and is not location dependent.)
  • •One or more of the following:
  • •Moderate/moderately severe depressive symptoms
  • •Chronic pain
  • •Presence of significant fatigue symptoms
  • •Read, speak and understand English.

Exclusion Criteria

  • •Significant cognitive impairment
  • •Current psychotherapy for symptoms

Arms & Interventions

My MS Toolkit

Experimental

20 Participants asked to use My MS Toolkit.

Intervention: My MS Toolkit (Other)

Outcomes

Primary Outcomes

Acceptability of My MS Toolkit

Time Frame: week 12-week 14

Assessed by the Patient Satisfaction Evaluation Scale, 12 question scale where each response score ranges from 4 to 1 and the total score ranges from 48 to 12. Higher scores indicate increased satisfaction.

Feasibility of My MS Toolkit

Time Frame: up to week 12

Assessed by the treatment adherence questionnaire that consists of 5 questions that assess: 1) how many times the participant accessed the website in the prior two weeks; 2) how many minutes the participant spent on the website; 3) which parts of the website the participant accessed; 4) which activities the participant engaged in; and 5) which skill from the website the participant used. The items on this questionnaire will be used to describe the use of the website for assessing treatment adherence by participants in the study.

Secondary Outcomes

  • Impact My MS Toolkit: Change in pain interference(up to 14 weeks)
  • Impact My MS Toolkit: Change in depressive symptoms(up to 14 weeks)
  • Change in self-efficacy for managing symptoms(up to 14 weeks)
  • Impact of My MS Toolkit: Change in fatigue(Pre- and post-treatment, up to 14 weeks)
  • Participant perception of change(week 12-14)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Anna Kratz

Associate Professor of Physical Medicine and Rehabilitation

University of Michigan

Study Sites (1)

Loading locations...

Similar Trials